Clinical Studies 14.1 Overview of Clinical Studies The effectiveness of OZEMPIC tablets (1.5 mg, 4 mg and 9 mg strengths) [see Dosage and Administration (2.2)] and RYBELSUS (3 mg, 7, mg and 14 mg strengths) [see Dosage and Administration (2.3)] has been established as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus based on adequate and well-controlled studies of RYBELSUS in adult patients with type 2 diabetes mellitus [see Clinical Pharmacology (12.3)]
A Harvard study published in JAMA Ophthalmology found that diabetic patients taking Semaglutide, which is the active ingredient in Ozempic, Wegovy, and Rybelsus, developed NAION at nearly five times the rate of those taking other medications over a three-year period
When we address the root causeswhen we give your body the support it needsthat weight can be released
A qualitative exploration of patient and staff experiences of the receipt and delivery of specialist weight management services in the UK
Tottoli EM, Dorati R, Genta I, Chiesa E, Pisani S, Conti B
I will never go anywhere else again